Monthly Archives: October 2019

Clinical Trials: Checking out what the FDA and EMA recommend about controlling for covariates

At work I recently finalized analyses for a clinical trial that had 4 arms (double blind with 3 dose levels and a placebo) testing a nutritional supplement which may be helpful for cognition.  There were measurements at baseline (before randomization) … Continue reading

Posted in Uncategorized | 1 Comment